Home / Pluripotent Stem Cells / StemXVivo Ectoderm Kit

StemXVivo Ectoderm Kit

Catalog #: SC031B
10 Citations Datasheet / COA / SDS
For ectoderm differentiation of human pluripotent stem cells
Catalog # Availability Size / Price Qty
SC031B
Differentiation of Pluripotent Stem Cells into Ectoderm.
2 Images
Product Details
Procedure
Citations (10)
FAQs
Reviews
Summary Product Datasheets Data Images Background

StemXVivo Ectoderm Kit Summary

Kit Summary

For the differentiation of human pluripotent stem cells into ectoderm.

Key Benefits

  • Ectoderm differentiation in 4 days
  • Optimized components to reduce experimental variation
  • Contains differentiation supplements and an antibody to verify ectoderm differentiation
  • Involves validated and straightforward protocols
 

Why Differentiate Human Pluripotent Stem Cells into Ectoderm In Vitro?

Ectoderm is one of three primary germ layers formed during the process of gastrulation in the vertebrate embryo and gives rise to the nervous system and epidermal tissues.

Ectoderm differentiation is also an essential first step for the formation of downstream derivative cell types for use in regenerative medicine, such as neurons and keratinocytes.

Ectoderm differentiation in vitro:

  • Uses fully defined supplements to drive reproducible differentiation.
  • Produces a healthy ectodermal cell population to increase consistency between studies and reduce unwanted experimental variability.
  • Provides results in 4 days to save time and reagents.

 

Kit Contents

This kit contains the following reagents to drive pluripotent stem cell differentiation into ectodermal cells and an antibody to verify differentiation status:

  • Ectoderm Base Media Supplement (50X)
  • Ectoderm Differentiation Supplement
  • Ectoderm Marker: Goat Anti-Human Otx2 Antigen Affinity-purified Polyclonal Antibody

The quantity of each component in this kit is sufficient to make 150 mL of media for differentiation. This is enough media for the differentiation of six 60 mm plates or two 24-well plates.

 

Specifications

Source
N/A
Shipping Conditions
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
Species
Human

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Scientific Data

Cell Differentiation/ Maturation Differentiation of Pluripotent Stem Cells into Ectoderm. View Larger

Differentiation of Pluripotent Stem Cells into Ectoderm. BG01V human embryonic stem cells were differentiated into ectoderm using the media supplements included in this kit. To evaluate lineage commitment, the cells were stained with the Anti-Human Otx2 antibody included. The cells were stained using NorthernLights™(NL)557-conjugated Donkey anti-Goat IgG secondary antibody (R&D Systems, Catalog # NL001; red), and the nuclei were counterstained with DAPI (blue).

Assay Procedure

Refer to the product datasheet for complete product details.

Briefly, human pluripotent stem cells are differentiated into ectoderm cells using the following ectoderm differentiation procedure:

  • Plate cells on coated plates
  • Replace MEF Conditioned Media with Differentiation Media
  • Evaluate differentiation status using the included Otx2 antibody
  • Cells are ready for downstream applications on Day 4
SC031B Protocol Graphic Summary
View Graphic Procedure
 

 

Reagents Provided

Reagents supplied in the StemXVivo® Ectoderm Kit (Catalog # SC031).

  • Ectoderm Base Media Supplement (50X)
  • Ectoderm Differentiation Supplement
  • Ectoderm Marker: Goat Anti-Human Otx2 Antigen Affinity-purified Polyclonal Antibody

 

Other Supplies Required

Reagents

  • RPMI Medium 1640
  • BSA, very low endotoxin
  • DMEM/F-12
  • GlutaMAX™ (Invitrogen), or equivalent
  • Penicillin-Streptomycin (optional)
  • Phosphate-Buffered Saline (PBS)
  • Cultrex® PathClear® Basement Membrane Extract Reduced Growth Factor (Catalog # 3433-005-01)
  • MEF Conditioned Media (Catalog # AR005)
  • Trypan Blue solution
  • Accutase® (Innovative Cell Technologies), or equivalent
  • 95% Ethanol
  • 4% Paraformaldehyde in PBS
  • 1% BSA
  • 0.3% Triton™ X-100, 1% BSA, 10% normal donkey serum in PBS
  • Mounting medium (Catalog # CTS011)
  • Secondary developing reagents (Catalog # NL001, NL002, or NL003)
  • Sterile, deionized water

Materials

  • Human pluripotent stem cells
  • 24-well culture plates
  • 12 mm cover slips
  • 15 mL centrifuge tubes
  • 50 mL centrifuge tubes
  • 0.2 μm syringe filter
  • 0.2 μm, 500 mL filter units
  • 10 mL syringes
  • Serological pipettes
  • Pipettes and pipette tips
  • Glass slides
  • Fine pointed curved forceps

Equipment

  • 37 °C and 5% CO2 incubator
  • 37 °C water bath
  • Centrifuge
  • Hemocytometer
  • Inverted microscope
  • Fluorescence microscope

Precaution: The acute and chronic effects of overexposure to reagents of this kit are unknown. Safe laboratory procedures should be followed and protective clothing should be worn when handling kit reagents.

Some components of this kit contain sodium azide, which may react with lead and copper plumbing to form explosive metallic azides. Flush with large volumes of water during disposal.

 

Procedure Overview

This protocol is designed for BG01V human embryonic stem cells grown in Mouse Embryonic Fibroblast (MEF) Conditioned Media (Catalog #AR005). If using different cell lines or growth media, this protocol may need to be optimized.

Coat wells with Cultrex® Basement Membrane Extract.

Incubate at room temperature for 1-2 hours.

SC031B Step 1&2

Plate human pluripotent stem cells onto the coated plates at 1.1 x 105 cells/cm2 in MEF Media containing FGF basic.

SC031B Step 3

Culture the cells overnight at 37 °C and 5% CO2.The next day each well should be approximately 50% confluent.

SC031B Step 4

Day 1 of Differentiation

Remove the MEF Conditioned Media with Ectoderm Differentiation Media.

Incubate at 37 °C and 5% CO2 for 12-24 hours.

SC031B Step 5&6

Days 2 and 3 of Differentiation

Refresh media

On Day 4, the cells are ready for further differentiation to downstream cell types or analysis by immunocytochemistry and/or flow cytometry.

SC031B Step 6

Citations for StemXVivo Ectoderm Kit

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

10 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Generation and characterization of induced pluripotent stem cells from breast cancer patients carrying ATM mutations
    Authors: Zhang, M;Venkateshappa, R;Li, A;Fowler, MB;Telli, ML;Wu, JC;
    Stem cell research  2023-11-06
  2. Generation of two induced pluripotent stem cell lines from breast cancer patients carrying BRCA2 variants
    Authors: Zhang, M;Liu, W;Li, A;Htet, MH;Yu, R;Telli, ML;Wu, JC;
    Stem cell research  2023-10-02
  3. A Mutant Methionyl-tRNA Synthetase-Based toolkit to assess induced-Mesenchymal Stromal Cell secretome in mixed-culture disease models
    Authors: Burgess, JD;Amerna, D;Norton, ES;Parsons, TM;Iii, RBP;Faroqi, AH;Wszolek, ZK;Cazares, HG;Kanekiyo, T;Delenclos, M;McLean, PJ;
    Research square  2023-05-03
  4. Fabrication Scaffold with High Dimensional Control for Spheroids with Undifferentiated iPS Cell Properties
    Authors: H Togo, K Terada, A Ujitsugu, Y Hirose, H Takeuchi, M Kusunoki
    Cells, 2023-01-11;12(2):.  2023-01-11
  5. Generation of two human iPSC lines with Exon 3 mutations in BCL2-Associated Athanogene 3 (BAG3) from dilated cardiomyopathy patients
    Authors: PH Zushin, Y Zhou, A Li, EA Ashley, MT Wheeler, JC Wu
    Stem Cell Research, 2023-01-05;67(0):103019.  2023-01-05
  6. Generation of two human iPSC lines with Exon 3 mutations in BCL2-Associated Athanogene 3 (BAG3) from dilated cardiomyopathy patients
    Authors: PH Zushin, Y Zhou, A Li, EA Ashley, MT Wheeler, JC Wu
    Stem Cell Research, 2023;67(0):103019.  2023
  7. Neonatal Porcine Germ Cells Dedifferentiate and Display Osteogenic and Pluripotency Properties
    Authors: MA Fayaz, GDS Rosa, A Honaramooz
    Cells, 2021-10-20;10(11):.  2021-10-20
  8. Colon adenocarcinoma-derived cells that express induced-pluripotent stem cell markers possess stem cell function
    Authors: MJ Munro, L Peng, SK Wickremese, ST Tan
    PLoS ONE, 2020-05-19;15(5):e0232934.  2020-05-19
  9. Generation of an induced pluripotent stem cell cohort suitable to investigate sporadic Alzheimer's Disease
    Authors: DC Schöndorf, M Elschami, M Schieck, E Ercan-Herb, C Weber, Y Riesinger, S Kalman, D Steinemann, DE Ehrnhoefer
    Stem Cell Res, 2018-12-05;34(0):101351.  2018-12-05
  10. Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs
    Sci Rep, 2016-08-23;6(0):32007.  2016-08-23

FAQs

No product specific FAQs exist for this product, however you may

View all Stem Cell Product FAQs

Reviews for StemXVivo Ectoderm Kit

There are currently no reviews for this product. Be the first to review StemXVivo Ectoderm Kit and earn rewards!

Have you used StemXVivo Ectoderm Kit?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review